:

NEARLY 30% OF AMERICANS USE AI FOR HEALTH INFO

AI DESK1 MIN READ
WED, AUG 26, 2026

■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE

A Pew Research Center survey found that 28% of Americans turn to AI chatbots for quick health information, with most users finding the results helpful. The trend reflects growing reliance on artificial intelligence for medical guidance.

Beyond speed, Americans use chatbots for specific health tasks. Twenty-five percent leverage AI to identify potential causes of symptoms, while 22% cite cost savings as a primary reason for using the technology. Common uses include making diagnoses, learning about lab results, and understanding treatment options. The survey indicates nearly all chatbot health users consider the information they receive useful. The findings underscore a significant shift in how Americans approach health information. AI chatbots offer instant access to medical knowledge without the wait times or expenses associated with traditional healthcare consultations. However, the data highlights a growing disconnect between AI usage and professional medical consultation. While chatbots provide convenient information, they remain unregulated sources without the accountability of licensed physicians. Pew's research captures a moment of rapid AI adoption in healthcare, demonstrating that accessibility and speed have become major factors in how Americans inform themselves about their health.

■ SOURCES

Techmeme

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE AI DESK

Despite early predictions that AI would eliminate radiologist jobs, the technology is instead transforming the role. Radiologists are evolving from image interpreters to clinical decision-makers working alongside AI systems.

JUST NOWAI Desk

Bill Gates says the artificial intelligence era represents one of history's most disruptive periods and that governments and institutions are unprepared. He is calling for a regulatory framework to manage the transition.

JUST NOWAI Desk

DeepSeek generated $70.7 million in revenue during the first seven months of 2026 while posting a $106 million net loss, according to sources cited by The Information. The figures represent roughly 10x the Chinese AI startup's full-year 2025 revenue.

JUST NOWIndustry Desk

Niu Zhangming, founder and CEO of AI biotech firm Mindrank AI, detailed the company's business strategy and approach to artificial intelligence in pharmaceutical development at the Asia Innovation and Technology Enterprises Going Global Summit in Hong Kong.

4H AGOAI Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.